Pharmacoeconomic Comparison of Anaprazole and I...

By Melike Belenli Gümüş

July 2, 2024

Introduction Peptic ulcer disease (PUD) affects 5%–10% of the global po...
The Role of Real-World Evidence in CMS Price Negotiations
Enhancing Global Health through Cost-Effectiveness Analysis
The Role of Pull Incentives in Addressing Antimicrobial Resistance
A Cost-Saving Life-Saver: The Impact of Palivizumab in Columbia
Tuberculosis Care in Indonesia: A Financial Analysis of Strategic Purchasing ...
Cost-Effectiveness of IDegAsp in Diabetes Management: Insights from ARISE Study
Understanding the Cost and Clinical Impact of Multisystem Inflammatory Syndro...
Striking the Balance: Optimising Hepatitis B Treatment Strategies in The Gambia
Cost-Utility and Cost-Effectiveness of Disease-Modifying Drugs for Relapsing-...
The Economic Benefits of Preventive Health Programs
The Shift to Value-Based Drug Pricing in the United States
Cost Savings on Generic Drugs: Transparent Pricing Models